D&D Pharmatech showed a strong upward trend during trading on the 24th, recovering to the 90,000-won range.

As of the morning session that day, D&D Pharmatech traded at 99,500 won, up 3,400 won (3.54%) from the previous trading day. Building on the previous day's upward momentum, an influx of buying interest pushed prices into the upper 90,000-won range. Trading volume exceeded 570,000 shares, reflecting high investor interest.

The market sees growing expectations for D&D Pharmatech's research and development achievements and the potential expansion of its global business as being reflected in the stock price, amid improving investor sentiment toward the overall bio sector recently.

However, caution regarding external variables remains. Global financial markets are closely watching the release of U.S. economic indicators, comments from Federal Reserve (Fed) officials, and the future interest rate path. In particular, major technology stocks centered on artificial intelligence (AI) and semiconductors have recently undergone short-term corrections in the U.S. stock market, leading to increased volatility. Market participants are monitoring the extent of tech stock corrections and U.S. economic indicator results to gauge changes in risk appetite.

Securities firms analyze that since the stock price trajectory of bio sector companies can vary significantly depending on individual clinical and business results, it is necessary to continuously monitor related disclosures and R&D progress.

[※ This article was written with AI assistance based on publicly available data and market information. The content included in this article is for reference purposes only for investment decisions and does not constitute a recommendation to buy or sell any specific stock or guarantee any returns. The stock market can fluctuate due to various variables, so investment decisions should be made based on the investor's own judgment and responsibility. As there may be some misinterpretation or errors of information during the AI analysis process, please be sure to verify disclosure materials and company announcements before making final investment decisions.]